{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:31:10Z","timestamp":1787023870858,"version":"build-2736575974"},"reference-count":94,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,7]]},"DOI":"10.20945\/2359-3997000000600","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T07:42:04Z","timestamp":1675842124000},"source":"Crossref","is-referenced-by-count":5,"title":["The molecular pathogenesis of craniopharyngiomas"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3203-0151","authenticated-orcid":false,"given":"Marina Lanciotti","family":"Campanini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9930-3807","authenticated-orcid":false,"given":"Jo\u00e3o Paulo","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3601-9470","authenticated-orcid":false,"given":"Clarissa Silva","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4932-4623","authenticated-orcid":false,"given":"Margaret","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"key":"key20230208072308_B1","first-page":"141","volume-title":"Neuroendocrinologia \u2013 SBEM","author":"Martins","year":"2020","unstructured":"Martins C, Silva JISM, Machado, HR, de Castro M. Craniofaringioma: Epidemiologia, classifica\u00e7\u00e3o e bases moleculares. In: Garmes HM, Boguszewski CL, eds. Neuroendocrinologia \u2013 SBEM. S\u00e3o Paulo: Clannad; 2020. p. 141-8."},{"issue":"3","key":"key20230208072308_B2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s11060-011-0540-6","article-title":"Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults","volume":"104","author":"Nielsen","year":"2011","unstructured":"Nielsen EH, Feldt-Rasmussen U, Poulsgaard L, Kristensen L, Astrup J, J\u00f8rgensen JO, et al. Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults. J Neurooncol. 2011;104(3):755-63.","journal-title":"J Neurooncol"},{"issue":"6","key":"key20230208072308_B3","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1227\/00006123-199412000-00001","article-title":"Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome","volume":"35","author":"Weiner","year":"1994","unstructured":"Weiner HL, Wisoff JH, Rosenberg ME, Kupersmith MJ, Cohen, Henry MPH, et al. Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery. 1994;35(6):1001-11.","journal-title":"Neurosurgery"},{"issue":"1","key":"key20230208072308_B4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ecl.2007.10.012","article-title":"Craniopharyngiomas","volume":"37","author":"Karavitaki","year":"2008","unstructured":"Karavitaki N, Wass JAH. Craniopharyngiomas. Endocrinol Metab Clin North Am. 2008;37(1):173-93.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"key20230208072308_B5","first-page":"51","article-title":"Comparison of neuroendocrine dysfunction in patients with adamantinomatous and papillary craniopharyngiomas","volume":"17","author":"Feng","year":"2019","unstructured":"Feng Y, Ni M, Wang YG, Zhong LY. Comparison of neuroendocrine dysfunction in patients with adamantinomatous and papillary craniopharyngiomas. Exp Ther Med. 2019;17(1):51-6.","journal-title":"Exp Ther Med"},{"issue":"4","key":"key20230208072308_B6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11102-021-01127-6","article-title":"Descriptive epidemiology of craniopharyngiomas in the United States","volume":"24","author":"Momin","year":"2021","unstructured":"Momin A, Recinos M, Cioffi G, Patil N, Soni P, Almeida J, et al. Descriptive epidemiology of craniopharyngiomas in the United States. Pituitary. 2021;24(4):517-22.","journal-title":"Pituitary"},{"issue":"10","key":"key20230208072308_B7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1159\/000512161","article-title":"Craniopharyngioma in the elderly: a multicenter and nationwide study in Spain","volume":"111","author":"Iglesias","year":"2021","unstructured":"Iglesias P, Nocete I, Moure Rodr\u00edguez MD, Venegas-Moreno E, Ares J, Biagetti B, et al. Craniopharyngioma in the elderly: a multicenter and nationwide study in Spain. Neuroendocrinology. 2021;111(10):925-36.","journal-title":"Neuroendocrinology"},{"issue":"4","key":"key20230208072308_B8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s11102-008-0165-8","article-title":"Craniopharyngioma: historical notes","volume":"12","author":"Lindholm","year":"2009","unstructured":"Lindholm J, Nielsen EH. Craniopharyngioma: historical notes. Pituitary. 2009;12(4):352-9.","journal-title":"Pituitary"},{"issue":"2","key":"key20230208072308_B9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000120827","article-title":"A critical review of personal experiences with craniopharyngioma: clinical history, surgical technique and operative results","volume":"21","author":"Raimondi","year":"1994","unstructured":"Raimondi AJ, Rougerie J. A critical review of personal experiences with craniopharyngioma: clinical history, surgical technique and operative results. Pediatr Neurosurg. 1994;21(2):134-54.","journal-title":"Pediatr Neurosurg"},{"issue":"4","key":"key20230208072308_B10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1210\/er.2006-0002","article-title":"Craniopharyngiomas","volume":"27","author":"Karavitaki","year":"2006","unstructured":"Karavitaki N, Cudlip S, Adams CBT, Wass JAH. Craniopharyngiomas. Endocr Rev. 2006;27(4):371-97.","journal-title":"Endocr Rev"},{"key":"key20230208072308_B11","first-page":"93","volume-title":"Intracranial Tumours","author":"Cushing","year":"1932","unstructured":"Cushing H. The craniopharyngioma. In: Cushing H. Intracranial Tumours. London: Bailliere, Tindall & Cox; 1932. p. 93-8."},{"issue":"6","key":"key20230208072308_B12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803-20.","journal-title":"Acta Neuropathol"},{"key":"key20230208072308_B13","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.wneu.2020.05.174","article-title":"Current results of surgical treatment of raniopharyngiomas: the impact of endoscopic endonasal approaches","volume":"142","author":"Almeida","year":"2020","unstructured":"Almeida JP, Kalyvas A, Mohan N, Oswari S, Takami H, Velasquez C, et al. Current results of surgical treatment of raniopharyngiomas: the impact of endoscopic endonasal approaches. World Neurosurg. 2020;142:582-92.","journal-title":"World Neurosurg"},{"issue":"3","key":"key20230208072308_B14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/er.2013-1115","article-title":"Craniopharyngioma","volume":"35","author":"M\u00fcller","year":"2014","unstructured":"M\u00fcller HL. Craniopharyngioma. Endocr Rev. 2014;35(3):513-43.","journal-title":"Endocr Rev"},{"issue":"9-10","key":"key20230208072308_B15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1159\/000504512","article-title":"The diagnosis and treatment of craniopharyngioma","volume":"110","author":"M\u00fcller","year":"2020","unstructured":"M\u00fcller HL. The diagnosis and treatment of craniopharyngioma. Neuroendocrinology. 2020;110(9-10):753-66.","journal-title":"Neuroendocrinology"},{"issue":"3","key":"key20230208072308_B16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ecl.2020.05.009","article-title":"Management of hypothalamic obesity","volume":"49","author":"M\u00fcller","year":"2020","unstructured":"M\u00fcller HL. Management of hypothalamic obesity. Endocrinol Metab Clin North Am. 2020;49(3):533-52.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"key20230208072308_B17","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1016\/j.clnesp.2015.06.001","article-title":"Nutritional and endocrinologic evaluation of patients with craniopharyngioma","volume":"10","author":"Nogueira","year":"2015","unstructured":"Nogueira MC, Berbel J\u00fanior AS, Koenigkam-Santos M, Moreira AC, Nonino CB, de Castro M. Nutritional and endocrinologic evaluation of patients with craniopharyngioma. Clin Nutr ESPEN. 2015;10(6):e213-8.","journal-title":"Clin Nutr ESPEN"},{"key":"key20230208072308_B18","first-page":"447","article-title":"A multimodality approach to the treatment of craniopharyngiomas avoiding hypothalamic morbidity: a UK perspective","volume":"19","author":"Spoudeas","year":"2006","unstructured":"Spoudeas HA, Saran F, Pizer Z. A multimodality approach to the treatment of craniopharyngiomas avoiding hypothalamic morbidity: a UK perspective. J Pediatr Endocrinol Metab. 2006;19(Suppl 1):447-51.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"9","key":"key20230208072308_B19","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00381-009-0931-6","article-title":"Practical approach to childhood craniopharyngioma: a role of an endocrinologist and a general paediatrician","volume":"25","author":"Kalina","year":"2009","unstructured":"Kalina MA, Skala-Zamorowska E, Kalina-Faska B, Malecka-Tendera E, Mandera M. Practical approach to childhood craniopharyngioma: a role of an endocrinologist and a general paediatrician. Child's Nerv Syst. 2009;25(9):1053-60.","journal-title":"Child's Nerv Syst"},{"key":"key20230208072308_B20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-3-030-41176-3_10","volume-title":"Adult Craniopharyngiomas: Differences and Lessons from Paediatrics","author":"M\u00fcller","year":"2020","unstructured":"M\u00fcller HL. Disease and treatment-related hypothalamic alterations in craniopharyngioma: clinical presentation, prognostic impact, and implications for treatment strategies. In: Jouanneau E, Raverot G. Adult Craniopharyngiomas: Differences and Lessons from Paediatrics. Cham: Springer; 2020. p. 157-86."},{"issue":"1","key":"key20230208072308_B21","first-page":"1","article-title":"Craniopharyngioma","volume":"5","author":"M\u00fcller","year":"2019","unstructured":"M\u00fcller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S. Craniopharyngioma. Nat Rev Dis Prim. 2019;5(1):1-19.","journal-title":"Nat Rev Dis Prim"},{"issue":"1","key":"key20230208072308_B22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1006145724500","article-title":"Health status in 52 long-term survivors of pediatric brain tumors","volume":"41","author":"Foreman","year":"1999","unstructured":"Foreman NK, Faestel PM, Pearson J, Disabato J, Poole M, Wilkening G, et al. Health status in 52 long-term survivors of pediatric brain tumors. J Neurooncol. 1999;41(1):47-53.","journal-title":"J Neurooncol"},{"issue":"1","key":"key20230208072308_B23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-015-0211-5","article-title":"Identification of targets for rational pharmacological therapy in childhood craniopharyngioma","volume":"3","author":"Gump","year":"2015","unstructured":"Gump JM, Donson AM, Birks DK, Amani VM, Rao KK, Griesinger AM, et al. Identification of targets for rational pharmacological therapy in childhood craniopharyngioma. Acta Neuropathol Commun. 2015;3(1):1-12.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"key20230208072308_B24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1210\/clinem\/dgz043","article-title":"Report from the German craniopharyngioma registry","volume":"105","author":"Mende","year":"2020","unstructured":"Mende KC, Kellner T, Petersenn S, Honegger J, Evangelista-Zamora R, Droste M, et al. Report from the German craniopharyngioma registry. J Clin Endocrinol Metab. 2020;105(1):252-65.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1-2","key":"key20230208072308_B25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/path.1700690120","article-title":"Squamous metaplasia of cells of the anterior pituitary gland","volume":"69","author":"Hunter","year":"1955","unstructured":"Hunter IJ. Squamous metaplasia of cells of the anterior pituitary gland. J Pathol Bacteriol. 1955;69(1-2):141-5.","journal-title":"J Pathol Bacteriol"},{"issue":"3","key":"key20230208072308_B26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF00687750","article-title":"Immunohistochemical localization of keratin in craniopharyngiomas and squamous cell nests of the human pituitary","volume":"54","author":"Asa","year":"1981","unstructured":"Asa SL, Kovacs K, Bilbao JM, Penz G. Immunohistochemical localization of keratin in craniopharyngiomas and squamous cell nests of the human pituitary. Acta Neuropathol. 1981;54(3):257-60.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"key20230208072308_B27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF00666218","article-title":"The pars tuberalis of the human pituitary","volume":"399","author":"Asa","year":"1983","unstructured":"Asa SL, Kovacs K, Bilbao JM. The pars tuberalis of the human pituitary. Virchows Arch A Pathol Anat Histopathol. 1983;399(1):49-59.","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"issue":"1","key":"key20230208072308_B28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1242\/dev.122.1.41","article-title":"Rpx: a novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathke's pouch of the mouse embryo","volume":"122","author":"Hermesz","year":"1996","unstructured":"Hermesz E, Mackem S, Mahon KA. Rpx: a novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathke's pouch of the mouse embryo. Development. 1996;122(1):41-52.","journal-title":"Development"},{"issue":"12","key":"key20230208072308_B29","first-page":"1570","article-title":"The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage-specific cell proliferation","volume":"10","author":"Gage","year":"1996","unstructured":"Gage PJ, Brinkmeier ML, Scarlett LM, Knapp LT, Camper SA, Mahon KA. The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage-specific cell proliferation. Mol Endocrinol. 1996;10(12):1570-81.","journal-title":"Mol Endocrinol"},{"issue":"6607","key":"key20230208072308_B30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/384327a0","article-title":"Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism","volume":"384","author":"Sornson","year":"1996","unstructured":"Sornson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, O\u2019Connell SM, et al. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature. 1996;384(6607):327-33.","journal-title":"Nature"},{"issue":"7","key":"key20230208072308_B31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0168-9525(98)01476-0","article-title":"How many homeobox genes does it take to make a pituitary gland?","volume":"14","author":"Watkins-Chow","year":"1998","unstructured":"Watkins-Chow DE, Camper SA. How many homeobox genes does it take to make a pituitary gland? Trends Genet. 1998;14(7):284-90.","journal-title":"Trends Genet"},{"issue":"2","key":"key20230208072308_B32","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1006\/dbio.2000.9757","article-title":"The homeobox gene Hesx1 is required in the anterior neural ectoderm for normal forebrain formation","volume":"223","author":"Martinez-Barbera","year":"2000","unstructured":"Martinez-Barbera JP, Rodriguez TA, Beddington RSP. The homeobox gene Hesx1 is required in the anterior neural ectoderm for normal forebrain formation. Dev Biol. 2000;223(2):422-30.","journal-title":"Dev Biol"},{"issue":"3","key":"key20230208072308_B33","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1227\/01.NEU.0000373013.75994.CD","article-title":"Pituitary stem cells: review of the literature and current understanding","volume":"67","author":"De Almeida","year":"2010","unstructured":"De Almeida JPC, Sherman JH, Salvatori R, Qui\u00f1ones-Hinojosa A. Pituitary stem cells: review of the literature and current understanding. Neurosurgery. 2010;67(3):770-80.","journal-title":"Neurosurgery"},{"issue":"9-10","key":"key20230208072308_B34","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1159\/000506904","article-title":"Biological behaviour of craniopharyngiomas","volume":"110","author":"Martinez-Barbera","year":"2020","unstructured":"Martinez-Barbera JP, Andoniadou CL. Biological behaviour of craniopharyngiomas. Neuroendocrinology. 2020;110(9-10):797-804.","journal-title":"Neuroendocrinology"},{"issue":"579","key":"key20230208072308_B35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1259\/0007-1285-49-579-206","article-title":"Craniopharyngioma: based on 160 cases","volume":"49","author":"Banna","year":"1976","unstructured":"Banna M. Craniopharyngioma: based on 160 cases. Br J Radiol. 1976;49(579):206-23.","journal-title":"Br J Radiol"},{"issue":"3","key":"key20230208072308_B36","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/path.1562","article-title":"Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma","volume":"203","author":"Kato","year":"2004","unstructured":"Kato K, Nakatani Y, Kanno H, Inayama Y, Ijiri R, Nagahara N, et al. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol. 2004;203(3):814-21.","journal-title":"J Pathol"},{"issue":"6","key":"key20230208072308_B37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00401-005-1004-x","article-title":"Common mutations of \u03b2-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region","volume":"109","author":"Buslei","year":"2005","unstructured":"Buslei R, Nolde M, Hofmann B, Meissner S, Eyupoglu IY, Siebzehnr\u00fcbl F, et al. Common mutations of \u03b2-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol. 2005;109(6):589-97.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"key20230208072308_B38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12672-010-0041-7","article-title":"CTNNB1 gene mutations, pituitary transcription factors, and microRNA expression involvement in the pathogenesis of adamantinomatous craniopharyngiomas","volume":"1","author":"Campanini","year":"2010","unstructured":"Campanini ML, Colli LM, Paixao BMC, Cabral TPF, Amaral FC, Machado HR, et al. CTNNB1 gene mutations, pituitary transcription factors, and microRNA expression involvement in the pathogenesis of adamantinomatous craniopharyngiomas. Horm Cancer. 2010;1(4):187-96.","journal-title":"Horm Cancer"},{"issue":"28","key":"key20230208072308_B39","doi-asserted-by":"crossref","first-page":"11482","DOI":"10.1073\/pnas.1101553108","article-title":"Increased Wingless (Wnt) signaling in pituitary progenitor\/stem cells gives rise to pituitary tumors in mice and humans","volume":"108","author":"Gaston-Massuet","year":"2011","unstructured":"Gaston-Massuet C, Andoniadou CL, Signore M, Jayakody SA, Charolidi N, Kyeyune R, et al. Increased Wingless (Wnt) signaling in pituitary progenitor\/stem cells gives rise to pituitary tumors in mice and humans. Proc Natl Acad Sci U S A. 2011;108(28):11482-7.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"key20230208072308_B40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00401-012-0957-9","article-title":"Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma","volume":"124","author":"Andoniadou","year":"2012","unstructured":"Andoniadou CL, Gaston-Massuet C, Reddy R, Schneider RP, Blasco MA, Le Tissier P, et al. Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma. Acta Neuropathol. 2012;124(2):259-71.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"key20230208072308_B41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng.2868","article-title":"Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas","volume":"46","author":"Brastianos","year":"2014","unstructured":"Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, Dias-Santagata D, Thorner AR, et al. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet. 2014;46(2):161-5.","journal-title":"Nat Genet"},{"issue":"4","key":"key20230208072308_B42","doi-asserted-by":"crossref","first-page":"R139","DOI":"10.1530\/EJE-15-0957","article-title":"BRAF V600E mutations in papillary craniopharyngioma","volume":"174","author":"Brastianos","year":"2016","unstructured":"Brastianos PK, Santagata S. BRAF V600E mutations in papillary craniopharyngioma. Eur J Endocrinol. 2016;174(4):R139-44.","journal-title":"Eur J Endocrinol"},{"key":"key20230208072308_B43","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40478-016-0287-6","article-title":"Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles","volume":"4","author":"H\u00f6lsken","year":"2016","unstructured":"H\u00f6lsken A, Sill M, Merkle J, Schweizer L, Buchfelder M, Flitsch J, et al. Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles. Acta Neuropathol Commun. 2016;4:20.","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"key20230208072308_B44","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3171\/jns.1995.83.2.0206","article-title":"Papillary craniopharyngioma: a clinicopathological study of 48 cases","volume":"83","author":"Crotty","year":"1995","unstructured":"Crotty TB, Scheithauer BW, Young WF, Davis DH, Shaw EG, Miller GM, et al. Papillary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg. 1995;83(2):206-14.","journal-title":"J Neurosurg"},{"issue":"4","key":"key20230208072308_B45","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s11102-012-0451-3","article-title":"Acute presentation of craniopharyngioma in children and adults in a Danish national cohort","volume":"16","author":"Nielsen","year":"2013","unstructured":"Nielsen EH, J\u00f8rgensen JO, Bjerre P, Andersen M, Andersen C, Feldt-Rasmussen U, et al. Acute presentation of craniopharyngioma in children and adults in a Danish national cohort. Pituitary. 2013;16(4):528-35.","journal-title":"Pituitary"},{"issue":"1","key":"key20230208072308_B46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11102-012-0418-4","article-title":"Pathology and pathogenesis of craniopharyngiomas","volume":"16","author":"Larkin","year":"2013","unstructured":"Larkin SJ, Ansorge O. Pathology and pathogenesis of craniopharyngiomas. Pituitary. 2013;16(1):9-17.","journal-title":"Pituitary"},{"key":"key20230208072308_B47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12688\/f1000research.11549.1","article-title":"Recent advances in molecular pathology of craniopharyngioma","volume":"6","author":"Larkin","year":"2017","unstructured":"Larkin S, Karavitaki N. Recent advances in molecular pathology of craniopharyngioma. F1000 Res. 2017;6:1-9.","journal-title":"F1000 Res"},{"issue":"2","key":"key20230208072308_B48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djv310","article-title":"Dramatic response of BRAF V600E mutant papillary craniopharyngioma to targeted therapy","volume":"108","author":"Brastianos","year":"2016","unstructured":"Brastianos PK, Shankar GM, Gill CM, Taylor-Weiner A, Nayyar N, Panka DJ, et al. Dramatic response of BRAF V600E mutant papillary craniopharyngioma to targeted therapy. J Natl Cancer Inst. 2016;108(2):1-5.","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"key20230208072308_B49","first-page":"2141","article-title":"MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma","volume":"144","author":"Haston","year":"2017","unstructured":"Haston S, Pozzi S, Carreno G, Manshaei S, Panousopoulos L, Gonzalez-Meljem JM, et al. MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma. Development. 2017;144(12):2141-52.","journal-title":"Development"},{"key":"key20230208072308_B50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-3-030-41176-3_2","volume-title":"Adult Craniopharyngiomas: Differences and Lessons from Paediatrics","author":"Apps","year":"2020","unstructured":"Apps JR, Martinez-Barbera JP. Mouse models of craniopharyngioma. In: Jouanneau E, Raverot G. Adult Craniopharyngiomas: Differences and Lessons from Paediatrics. Cham: Springer International Publishing; 2020. p. 19-33."},{"issue":"17","key":"key20230208072308_B51","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1002\/cncr.32197","article-title":"Targeted treatment of papillary craniopharyngiomas harboring BRAFV600E mutations","volume":"125","author":"Juratli","year":"2019","unstructured":"Juratli TA, Jones PS, Wang N, Subramanian M, Aylwin SJB, Odia Y, et al. Targeted treatment of papillary craniopharyngiomas harboring BRAFV600E mutations. Cancer. 2019;125(17):2910.","journal-title":"Cancer"},{"issue":"31","key":"key20230208072308_B52","doi-asserted-by":"crossref","first-page":"50564","DOI":"10.18632\/oncotarget.10501","article-title":"TREM-1 expression in craniopharyngioma and Rathke's cleft cyst: its possible implication for controversial pathology","volume":"7","author":"Liu","year":"2016","unstructured":"Liu Y, Wang CH, Li DL, Zhang SC, Peng YP, Peng J, et al. TREM-1 expression in craniopharyngioma and Rathke's cleft cyst: its possible implication for controversial pathology. Oncotarget. 2016;7(31):50564-74.","journal-title":"Oncotarget"},{"issue":"1","key":"key20230208072308_B53","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11060-018-2776-x","article-title":"The diagnostic value of preoperative inflammatory markers in craniopharyngioma: a multicenter cohort study","volume":"138","author":"Chen","year":"2018","unstructured":"Chen M, Zheng SH, Yang M, Chen ZH, Li ST. The diagnostic value of preoperative inflammatory markers in craniopharyngioma: a multicenter cohort study. J Neurooncol. 2018;138(1):113-22.","journal-title":"J Neurooncol"},{"issue":"8","key":"key20230208072308_B54","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/neuonc\/noy035","article-title":"Multiplexed immunofluorescence reveals potential PD-1\/PD-L1 pathway vulnerabilities in craniopharyngioma","volume":"20","author":"Coy","year":"2018","unstructured":"Coy S, Rashid R, Lin JR, Du Z, Donson AM, Hankinson TC, et al. Multiplexed immunofluorescence reveals potential PD-1\/PD-L1 pathway vulnerabilities in craniopharyngioma. Neuro Oncol. 2018;20(8):1101-12.","journal-title":"Neuro Oncol"},{"issue":"4","key":"key20230208072308_B55","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3171\/jns.1998.89.4.0547","article-title":"The descriptive epidemiology of craniopharyngioma","volume":"89","author":"Bunin","year":"1998","unstructured":"Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J Neurosurg. 1998;89(4):547-51.","journal-title":"J Neurosurg"},{"issue":"1","key":"key20230208072308_B56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-020-00939-0","article-title":"Transcriptional analyses of adult and pediatric adamantinomatous craniopharyngioma reveals similar expression signatures regarding potential therapeutic targets","volume":"8","author":"Prince","year":"2020","unstructured":"Prince E, Whelan R, Donson A, Staulcup S, Hengartner A, Vijmasi T, et al. Transcriptional analyses of adult and pediatric adamantinomatous craniopharyngioma reveals similar expression signatures regarding potential therapeutic targets. Acta Neuropathol Commun. 2020;8(1):1-10.","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"key20230208072308_B57","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/1097-0142(197604)37:4<1944::AID-CNCR2820370446>3.0.CO;2-#","article-title":"Craniopharyngiomas: a clinical and pathological review","volume":"37","author":"Petito","year":"1976","unstructured":"Petito CK, DeGirolami U, Earle KM. Craniopharyngiomas: a clinical and pathological review. Cancer. 1976;37(4):1944-52.","journal-title":"Cancer"},{"issue":"8-9","key":"key20230208072308_B58","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00381-005-1190-9","article-title":"The pathogenesis of craniopharyngiomas","volume":"21","author":"Prabhu","year":"2005","unstructured":"Prabhu VC, Brown HG. The pathogenesis of craniopharyngiomas. Child's Nerv Syst. 2005;21(8-9):622-7.","journal-title":"Child's Nerv Syst"},{"issue":"6","key":"key20230208072308_B59","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2559.2004.02029.x","article-title":"Expression of enamel proteins and LEF1 in adamantinomatous craniopharyngioma: evidence for its odontogenic epithelial differentiation","volume":"45","author":"Sekine","year":"2004","unstructured":"Sekine S, Takata T, Shibata T, Mori M, Morishita Y, Noguchi M, et al. Expression of enamel proteins and LEF1 in adamantinomatous craniopharyngioma: evidence for its odontogenic epithelial differentiation. Histopathology. 2004;45(6):573-9.","journal-title":"Histopathology"},{"issue":"3","key":"key20230208072308_B60","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cell.2006.02.046","article-title":"Homeodomain-mediated \u03b2-catenin-dependent switching events dictate cell-lineage determination","volume":"125","author":"Olson","year":"2006","unstructured":"Olson LE, Tollkuhn J, Scafoglio C, Krones A, Zhang J, Ohgi KA, et al. Homeodomain-mediated \u03b2-catenin-dependent switching events dictate cell-lineage determination. Cell. 2006;125(3):593-605.","journal-title":"Cell"},{"issue":"3","key":"key20230208072308_B61","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0092-8674(01)00330-0","article-title":"The structure of the \u03b2-catenin\/E-cadherin complex and the molecular basis of diverse ligand recognition by \u03b2-catenin","volume":"105","author":"Huber","year":"2001","unstructured":"Huber AH, Weis WI. The structure of the \u03b2-catenin\/E-cadherin complex and the molecular basis of diverse ligand recognition by \u03b2-catenin. Cell. 2001;105(3):391-402.","journal-title":"Cell"},{"issue":"1","key":"key20230208072308_B62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12022-014-9341-8","article-title":"The Wnt signalling cascade and the adherens junction complex in craniopharyngioma tumorigenesis","volume":"26","author":"Preda","year":"2015","unstructured":"Preda V, Larkin SJ, Karavitaki N, Ansorge O, Grossman AB. The Wnt signalling cascade and the adherens junction complex in craniopharyngioma tumorigenesis. Endocr Pathol. 2015;26(1):1-8.","journal-title":"Endocr Pathol"},{"issue":"6","key":"key20230208072308_B63","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0002-9440(10)64477-X","article-title":"Craniopharyngiomas of adamantinomatous type harbor \u03b2-catenin gene mutations","volume":"161","author":"Sekine","year":"2002","unstructured":"Sekine S, Shibata T, Kokubu A, Morishita Y, Noguchi M, Nakanishi Y, et al. Craniopharyngiomas of adamantinomatous type harbor \u03b2-catenin gene mutations. Am J Pathol. 2002;161(6):1997-2001.","journal-title":"Am J Pathol"},{"issue":"5","key":"key20230208072308_B64","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/nan.12613","article-title":"CTNNB1 mutations are clonal in adamantinomatous craniopharyngioma","volume":"46","author":"Apps","year":"2020","unstructured":"Apps JR, Stache C, Gonzalez-Meljem JM, Gutteridge A, Chalker J, Jacques TS, et al. CTNNB1 mutations are clonal in adamantinomatous craniopharyngioma. Neuropathol Appl Neurobiol. 2020;46(5):510-4.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"key20230208072308_B65","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11102-018-0890-6","article-title":"Can tissue biomarkers reliably predict the biological behavior of craniopharyngiomas? A comprehensive overview","volume":"21","author":"Prieto","year":"2018","unstructured":"Prieto R, Pascual JM. Can tissue biomarkers reliably predict the biological behavior of craniopharyngiomas? A comprehensive overview. Pituitary. 2018;21(4):431-42.","journal-title":"Pituitary"},{"issue":"3","key":"key20230208072308_B66","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/path.1562","article-title":"Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma","volume":"203","author":"Kato","year":"2004","unstructured":"Kato K, Nakatani Y, Kanno H, Inayama Y, Ijiri R, Nagahara N, et al. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol. 2004;203(3):814-21.","journal-title":"J Pathol"},{"issue":"3","key":"key20230208072308_B67","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1750-3639.2008.00180.x","article-title":"Target gene activation of the Wnt signaling pathway in nuclear \u03b2-catenin accumulating cells of adamantinomatous craniopharyngiomas","volume":"19","author":"H\u00f6lsken","year":"2009","unstructured":"H\u00f6lsken A, Kreutzer J, Hofmann BM, Hans V, Oppel F, Buchfelder M, et al. Target gene activation of the Wnt signaling pathway in nuclear \u03b2-catenin accumulating cells of adamantinomatous craniopharyngiomas. Brain Pathol. 2009;19(3):357-64.","journal-title":"Brain Pathol"},{"issue":"6","key":"key20230208072308_B68","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/nan.12226","article-title":"Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma","volume":"41","author":"Martinez-Barbera","year":"2015","unstructured":"Martinez-Barbera JP. Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma. Neuropathol Appl Neurobiol. 2015;41(6):721-32.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"key20230208072308_B69","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1309\/EALEG7LD6W7167PX","article-title":"\u03b2-catenin is expressed aberrantly in tumors expressing shadow cells: pilomatricoma, craniopharyngioma, and calcifying odontogenic cyst","volume":"120","author":"Hassanein","year":"2003","unstructured":"Hassanein AM, Glanz SM, Kessler HP, Eskin TA, Liu C. \u03b2-catenin is expressed aberrantly in tumors expressing shadow cells: pilomatricoma, craniopharyngioma, and calcifying odontogenic cyst. Am J Clin Pathol. 2003;120(5):732-6.","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"key20230208072308_B70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0062424","article-title":"Components of the canonical and non-canonical Wnt pathways are not mis-expressed in pituitary tumors","volume":"8","author":"Colli","year":"2013","unstructured":"Colli LM, Saggioro F, Serafini LN, Camargo RC, Machado HR, Moreira AC, et al. Components of the canonical and non-canonical Wnt pathways are not mis-expressed in pituitary tumors. PLoS One. 2013;8(4):1-7.","journal-title":"PLoS One"},{"issue":"6","key":"key20230208072308_B71","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.anndiagpath.2015.10.002","article-title":"Aberrant membranous expression of \u03b2-catenin predicts poor prognosis in patients with craniopharyngioma","volume":"19","author":"Li","year":"2015","unstructured":"Li Z, Xu J, Huang S, You C. Aberrant membranous expression of \u03b2-catenin predicts poor prognosis in patients with craniopharyngioma. Ann Diagn Pathol. 2015;19(6):403-8.","journal-title":"Ann Diagn Pathol"},{"issue":"7","key":"key20230208072308_B72","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/a-0593-5956","article-title":"Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas","volume":"50","author":"Juc\u00e1","year":"2018","unstructured":"Juc\u00e1 CEB, Colli LM, Martins CS, Campanini ML, Paix\u00e3o B, Juc\u00e1 RV, et al. Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas. Horm Metab Res. 2018;50(7):575-81.","journal-title":"Horm Metab Res"},{"issue":"4","key":"key20230208072308_B73","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.18632\/oncotarget.23695","article-title":"Exon 3 mutations of CTNNB1 drive tumorigenesis: a review","volume":"9","author":"Gao","year":"2018","unstructured":"Gao C, Wang Y, Broaddus R, Sun L, Xue F, Zhang W. Exon 3 mutations of CTNNB1 drive tumorigenesis: a review. Oncotarget. 2018;9(4):5492-508.","journal-title":"Oncotarget"},{"issue":"5","key":"key20230208072308_B74","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00401-018-1830-2","article-title":"Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK\/ERK pathway as a novel therapeutic target","volume":"135","author":"Apps","year":"2018","unstructured":"Apps JR, Carreno G, Gonzalez-Meljem JM, Haston S, Guiho R, Cooper JE, et al. Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK\/ERK pathway as a novel therapeutic target. Acta Neuropathol. 2018;135(5):757-77.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"key20230208072308_B75","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/EJE-14-0934","article-title":"Sonic Hedgehog pathway is upregulated in adamantinomatous craniopharyngiomas","volume":"172","author":"Gomes","year":"2015","unstructured":"Gomes DC, Jamra SA, Leal LF, Colli LM, Campanini ML, Oliveira RS, et al. Sonic Hedgehog pathway is upregulated in adamantinomatous craniopharyngiomas. Eur J Endocrinol. 2015;172(5):603-8.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"key20230208072308_B76","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/jc.2011-2187","article-title":"Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET\/GFRA3 receptors","volume":"97","author":"Garcia-Lavandeira","year":"2012","unstructured":"Garcia-Lavandeira M, Saez C, Diaz-Rodriguez E, Perez-Romero S, Senra A, Dieguez C, et al. Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET\/GFRA3 receptors. J Clin Endocrinol Metab. 2012;97(1):80-7.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1-2","key":"key20230208072308_B77","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1515\/jpem-2014-0442","article-title":"Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models","volume":"28","author":"Martinez-Barbera","year":"2015","unstructured":"Martinez-Barbera JP, Buslei R. Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models. J Pediatr Endocrinol Metab. 2015;28(1-2):7-17.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"key20230208072308_B78","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1530\/ERC-18-0538","article-title":"SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma","volume":"26","author":"Carreno","year":"2019","unstructured":"Carreno G, Boult JKR, Apps J, Gonzalez-Meljem JM, Haston S, Guiho R, et al. SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma. Endocr Relat Cancer. 2019;26(3):355-66.","journal-title":"Endocr Relat Cancer"},{"key":"key20230208072308_B79","first-page":"1","volume-title":"Basic Research and Clinical Aspects of Adamantinomatous Craniopharyngioma","author":"H\u00f6lsken","year":"2017","unstructured":"H\u00f6lsken A. Pathogenesis of human ACP. In: Martinez-Barbera JP, Andoniadou CL, eds. Basic Research and Clinical Aspects of Adamantinomatous Craniopharyngioma. Cham: Springer International Publishing AG; 2017. p. 1-26."},{"issue":"13","key":"key20230208072308_B80","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1158\/1078-0432.CCR-10-2811","article-title":"EGFR signaling regulates tumor cell migration in craniopharyngiomas","volume":"17","author":"H\u00f6lsken","year":"2011","unstructured":"H\u00f6lsken A, Gebhardt M, Buchfelder M, Fahlbusch R, Bl\u00fcmcke I, Buslei R. EGFR signaling regulates tumor cell migration in craniopharyngiomas. Clin Cancer Res. 2011;17(13):4367-77.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"key20230208072308_B81","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/14737175.2018.1528874","article-title":"Childhood-onset craniopharyngioma: latest insights into pathology, diagnostics, treatment, and follow-up","volume":"18","author":"Bogusz","year":"2018","unstructured":"Bogusz A, M\u00fcller HL. Childhood-onset craniopharyngioma: latest insights into pathology, diagnostics, treatment, and follow-up. Expert Rev Neurother. 2018;18(10):793-806.","journal-title":"Expert Rev Neurother"},{"issue":"8","key":"key20230208072308_B82","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00381-020-04677-5","article-title":"Adamantinomatous craniopharyngioma in the molecular age and the potential of targeted therapies: a review","volume":"36","author":"Whelan","year":"2020","unstructured":"Whelan R, Hengartner A, Folzenlogen Z, Prince E, Hankinson TC. Adamantinomatous craniopharyngioma in the molecular age and the potential of targeted therapies: a review. Child's Nerv Syst. 2020;36(8):1635-42.","journal-title":"Child's Nerv Syst"},{"issue":"5","key":"key20230208072308_B83","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00401-006-0184-3","article-title":"Nuclear \u03b2-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas","volume":"113","author":"Buslei","year":"2007","unstructured":"Buslei R, H\u00f6lsken A, Hofmann B, Kreutzer J, Siebzehnrubl F, Hans V, et al. Nuclear \u03b2-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas. Acta Neuropathol. 2007;113(5):585-90.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"key20230208072308_B84","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/neuonc\/not195","article-title":"Tight junction protein claudin-1 is differentially expressed in craniopharyngioma subtypes and indicates invasive tumor growth","volume":"16","author":"Stache","year":"2014","unstructured":"Stache C, H\u00f6lsken A, Fahlbusch R, Flitsch J, Schlaffer SM, Buchfelder M, et al. Tight junction protein claudin-1 is differentially expressed in craniopharyngioma subtypes and indicates invasive tumor growth. Neuro Oncol. 2014;16(2):256-64.","journal-title":"Neuro Oncol"},{"issue":"3","key":"key20230208072308_B85","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00428-009-0873-0","article-title":"A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas","volume":"456","author":"Burghaus","year":"2010","unstructured":"Burghaus S, H\u00f6lsken A, Buchfelder M, Fahlbusch R, Riederer BM, Hans V, et al. A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas. Virchows Arch. 2010;456(3):287-300.","journal-title":"Virchows Arch"},{"issue":"4","key":"key20230208072308_B86","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.stem.2013.07.004","article-title":"Sox2+ stem\/progenitor cells in the adult mouse pituitary support organ homeostasis and have tumor-inducing potential","volume":"13","author":"Andoniadou","year":"2013","unstructured":"Andoniadou CL, Matsushima D, Mousavy Gharavy SN, Signore M, Mackintosh AI, Schaeffer M, et al. Sox2+ stem\/progenitor cells in the adult mouse pituitary support organ homeostasis and have tumor-inducing potential. Cell Stem Cell. 2013;13(4):433-45.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"key20230208072308_B87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01992-5","article-title":"Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngioma","volume":"8","author":"Gonzalez-Meljem","year":"2017","unstructured":"Gonzalez-Meljem JM, Haston S, Carreno G, Apps JR, Pozzi S, Stache C, et al. Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngioma. Nat Commun. 2017;8(1):1-14.","journal-title":"Nat Commun"},{"issue":"4","key":"key20230208072308_B88","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3233\/CBM-140397","article-title":"High expression levels of CXCL12 and CXCR4 predict recurrence of adamanti-nomatous craniopharyngiomas in children","volume":"14","author":"Gong","year":"2014","unstructured":"Gong J, Zhang H, Xing S, Li C, Ma Z, Jia G, et al. High expression levels of CXCL12 and CXCR4 predict recurrence of adamanti-nomatous craniopharyngiomas in children. Cancer Biomarkers. 2014;14(4):241-51.","journal-title":"Cancer Biomarkers"},{"issue":"12","key":"key20230208072308_B89","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1007\/s11064-011-0560-9","article-title":"Expression of matrix metalloproteinase-9, type IV collagen and vascular endothelial growth factor in adamantinous craniopharyngioma","volume":"36","author":"Xia","year":"2011","unstructured":"Xia Z, Liu W, Li S, Jia G, Zhang Y, Li C, et al. Expression of matrix metalloproteinase-9, type IV collagen and vascular endothelial growth factor in adamantinous craniopharyngioma. Neurochem Res. 2011;36(12):2346-51.","journal-title":"Neurochem Res"},{"issue":"9","key":"key20230208072308_B90","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/jnen\/nlx061","article-title":"Molecular analyses reveal inflammatory mediators in the solid component and cyst fluid of human adamantinomatous craniopharyngioma","volume":"76","author":"Donson","year":"2017","unstructured":"Donson AM, Apps J, Griesinger AM, Amani V, Witt DA, Anderson RCE, et al. Molecular analyses reveal inflammatory mediators in the solid component and cyst fluid of human adamantinomatous craniopharyngioma. J Neuropathol Exp Neurol. 2017;76(9):779-88.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"key20230208072308_B91","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/cncr.10281","article-title":"Angiogenesis in patients with craniopharyngiomas: correlation with treatment and outcome","volume":"94","author":"Vidal","year":"2002","unstructured":"Vidal S, Kovacs K, Lloyd RV, Meyer FB, Scheithauer BW. Angiogenesis in patients with craniopharyngiomas: correlation with treatment and outcome. Cancer. 2002;94(3):738-45.","journal-title":"Cancer"},{"issue":"3","key":"key20230208072308_B92","first-page":"131","article-title":"The role of Wnt signalling in angiogenesis","volume":"38","author":"Olsen","year":"2017","unstructured":"Olsen JJ, Pohl S\u00d6, Deshmukh A, Visweswaran M, Ward NC, Arfuso F, et al. The role of Wnt signalling in angiogenesis. Clin Biochem Rev. 2017;38(3):131-42.","journal-title":"Clin Biochem Rev"},{"key":"key20230208072308_B93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2019.00791","article-title":"Targeting IL-6 is a potential treatment for primary cystic craniopharyngioma","volume":"9","author":"Grob","year":"2019","unstructured":"Grob S, Mirsky DM, Donson AM, Dahl N, Foreman NK, Hoffman LM, et al. Targeting IL-6 is a potential treatment for primary cystic craniopharyngioma. Front Oncol. 2019;9:1-6.","journal-title":"Front Oncol"},{"issue":"1","key":"key20230208072308_B94","first-page":"1","article-title":"Adamantinomatous craniopharyngioma: moving toward targeted therapies","volume":"48","author":"Hengartner","year":"2019","unstructured":"Hengartner AC, Prince E, Vijmasi T, Hankinson TC. Adamantinomatous craniopharyngioma: moving toward targeted therapies. Neurosurg Focus. 2019;48(1):1-9.","journal-title":"Neurosurg Focus"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T07:43:29Z","timestamp":1675842209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/the-molecular-pathogenesis-of-craniopharyngiomas\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,7]]},"references-count":94,"alternative-id":["10.20945\/2359-3997000000600"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000600","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,7]]}}}